Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Research Rheum

Reading Rheum

Gail C. Davis, RN, EdD; Michael M. Ward, MD;  |  

Handpicked Reviews of Contemporary Literature

Within Our Reach Investigators’ Meeting Brings Together Junior and Senior Investigators

Soumya Raychaudhuri, MD, PhD  |  

The Within Our Reach Investigators’ Meeting, held in San Diego in June, was an incredible gathering of researchers funded through the ACR Research and Education Foundation’s (REF’s) Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. The focus on rheumatoid arthritis (RA) was unmistakable as investigators from around the country presented work ranging from very basic immunology to health outcomes. 

Open (Access) Sesame

Bruce N. Cronstein, MD  |  

The pros and perils of open access publishing

A New Beginning

Sherine Gabriel, MD  |  

The growth of Arthritis Care & Research into an independent journal

Our Interdisciplinary Outlook

Sherine Gabriel, MD, and Pamela Degotardi, PhD  |  

Rheumatologists and health professionals working together is one of our great strengths

Reading Rheum

David G. Borenstein, MD  |  

Handpicked Reviews of Contemporary Literature

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

  |  

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.